Biodesix, Inc. (NASDAQ:BDSX) Q4 2024 Earnings Call Transcript March 3, 2025
Biodesix, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.07.
Operator: Good day, and thank you for standing by. Welcome to the Biodesix, Inc. Q4 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question and answer session. To ask a question during the session, you’ll need to press star one one on...
